What is the P/S ratio for OptimizeRx Corp. (OPRX)?

The P/S ratio for OPRX stock is 1.69.

What is the estimated TTM average P/S ratio for OptimizeRx Corp. (OPRX)?

The estimated TTM average P/S ratio for OPRX stock is 1.69.

What is the estimated 3Y average P/S ratio for OptimizeRx Corp. (OPRX)?

The estimated 3Y average P/S ratio for OPRX stock is 2.13.

What is the estimated 5Y average P/S ratio for OptimizeRx Corp. (OPRX)?

The estimated 5Y average P/S ratio for OPRX stock is 3.14.

What is the estimated 10Y average P/S ratio for OptimizeRx Corp. (OPRX)?

The estimated 10Y average P/S ratio for OPRX stock is 5.39.

What is the estimated 15Y average P/S ratio for OptimizeRx Corp. (OPRX)?

The estimated 15Y average P/S ratio for OPRX stock is 5.98.

TGMCharts

Compounders Research Compare

Compare

OptimizeRx Corp.(OPRX)

Medical - Healthcare Information Services · Waltham, MA

$8.89+0.16 (+1.89%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

Compare

PS Ratio: 1.69

Name: OptimizeRx Corp. (OPRX) PS Ratio — historical time series
Creator: TGMCharts

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 1.69 is 46% below its estimated 5-year average of 3.14, near the low end of its estimated 5-year range (0.79–34.25).

As of 2026-10-06T16:33:57.674Z. 0.13% below its estimated 12-month average of 1.69.

Stored calculation inputs

Calculation as of: 2026-10-06T16:33:57.674Z.

Quote observation: 2026-10-06T16:30:29.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 166,727,691
TTM revenue · period ending 2026-06-30: 98,654,000

FMP input reference: 2e4cd533ac20a6f80cd606aebe48acc9b54aed9ffabeca25d6b8b689be79c8f7

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

PS Ratio

OPRX PS Ratio Chart

1.69

Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OPRX PS Ratio

OPRX Average PS Ratio Chart

OPRX PS Ratio

OPRX Current vs Average PS Ratio Chart

OPRX PS Ratio Metrics

PS RATIO

1.69

PS RATIO AVG TTM

1.69

PS RATIO AVG 3Y

2.13

PS RATIO AVG 5Y

3.14

PS RATIO AVG 10Y

5.39

PS RATIO AVG 15Y

5.98

PS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-0.13%

CURRENT VS 3Y AVG

-20.61%

CURRENT VS 5Y AVG

-46.11%

CURRENT VS 10Y AVG

-68.65%

CURRENT VS 15Y AVG

-71.72%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

4.19

median of 511 covered companies

CURRENT VS SECTOR MEDIAN

-59.67%

vs the sector median at left

OPRX Competitors' PS Ratio

OPRX

OptimizeRx Corp.

Current

Market Cap

$166.73M

PS Ratio

1.69

TTM Avg

1.69

3Y Avg

2.13

5Y Avg

3.14

MDWD

MediWound Ltd.

vs OPRX

Market Cap

$169.76M

PS Ratio

14.31

TTM Avg

12.04

3Y Avg

9.32

5Y Avg

6.72

QTRX

Quanterix Corporation

vs OPRX

Market Cap

$163.22M

PS Ratio

1.06

TTM Avg

1.56

3Y Avg

3.32

5Y Avg

5.03

NKTX

Nkarta, Inc.

vs OPRX

Market Cap

$170.28M

PS Ratio

N/A

TTM Avg

3112093.93

3Y Avg

3112093.93

5Y Avg

3112093.93

CUE

Cue Biopharma, Inc.

vs OPRX

Market Cap

$171.59M

PS Ratio

4.56

TTM Avg

4.86

3Y Avg

10.20

5Y Avg

38.22

ORGO

Organogenesis Holdings Inc.

vs OPRX

Market Cap

$171.14M

PS Ratio

0.37

TTM Avg

0.85

3Y Avg

0.95

5Y Avg

1.16

PEPG

PepGen Inc.

vs OPRX

Market Cap

$162.20M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CHRS

Coherus Oncology, Inc.

vs OPRX

Market Cap

$160.68M

PS Ratio

3.15

TTM Avg

3.40

3Y Avg

1.68

5Y Avg

2.05

PRQR

ProQR Therapeutics N.V.

vs OPRX

Market Cap

$172.71M

PS Ratio

8.04

TTM Avg

11.25

3Y Avg

14.65

5Y Avg

42.69

DTIL

Precision BioSciences, Inc.

vs OPRX

Market Cap

$173.89M

PS Ratio

3.86

TTM Avg

34.48

3Y Avg

14.27

5Y Avg

9.83

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
OptimizeRx Corp. (OPRX)	$166.73M	1.69	1.69	2.13	3.14
MediWound Ltd. (MDWD)vs ›	$169.76M	14.31	12.04	9.32	6.72
Quanterix Corporation (QTRX)vs ›	$163.22M	1.06	1.56	3.32	5.03
Nkarta, Inc. (NKTX)vs ›	$170.28M	N/A	3112093.93	3112093.93	3112093.93
Cue Biopharma, Inc. (CUE)vs ›	$171.59M	4.56	4.86	10.20	38.22
Organogenesis Holdings Inc. (ORGO)vs ›	$171.14M	0.37	0.85	0.95	1.16
PepGen Inc. (PEPG)vs ›	$162.20M	N/A	N/A	N/A	N/A
Coherus Oncology, Inc. (CHRS)vs ›	$160.68M	3.15	3.40	1.68	2.05
ProQR Therapeutics N.V. (PRQR)vs ›	$172.71M	8.04	11.25	14.65	42.69
Precision BioSciences, Inc. (DTIL)vs ›	$173.89M	3.86	34.48	14.27	9.83

How this was calculated

Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.

Revenue calculation and filing references
Fiscal period	Revenue	Source
Q3 FY2025Period ended 2025-09-30	$26,067,000	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07
Q4 FY2025Period ended 2025-12-31	$32,239,000	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12
Q1 FY2026Period ended 2026-03-31	$19,844,000	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13
Q2 FY2026Period ended 2026-06-30	$20,504,000	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13
TTM revenue	$98,654,000

Current P/S: $166,727,691 market capitalization ÷ $98,654,000 TTM revenue = 1.69x.

Market capitalization source: FMP quote. Quote observed 2026-10-06T16:30:29.000Z. Latest revenue period ended 2026-06-30.

Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.

P/S vs. estimated history

At 1.69, P/S is below its estimated 17-year median — higher than 7% of readings in its estimated 17-year history.

estimated 17-year low

0.79

median

5.87

estimated 17-year high

2075.74

estimated 17-year lowestimated 17-year high

Sales Valuation

P/S Ratio

1.69

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for OptimizeRx Corp. (OPRX)?: The P/S ratio for OPRX stock is 1.69.
Is OptimizeRx Corp.'s P/S ratio high or low?: The P/S ratio of 1.69 is 46% below its estimated 5-year average of 3.14, near the low end of its estimated 5-year range (0.79–34.25).
What is the estimated TTM average P/S ratio for OptimizeRx Corp. (OPRX)?: The estimated TTM average P/S ratio for OPRX stock is 1.69.
What is the estimated 3Y average P/S ratio for OptimizeRx Corp. (OPRX)?: The estimated 3Y average P/S ratio for OPRX stock is 2.13.
What is the estimated 5Y average P/S ratio for OptimizeRx Corp. (OPRX)?: The estimated 5Y average P/S ratio for OPRX stock is 3.14.
What is the estimated 10Y average P/S ratio for OptimizeRx Corp. (OPRX)?: The estimated 10Y average P/S ratio for OPRX stock is 5.39.
What is the estimated 15Y average P/S ratio for OptimizeRx Corp. (OPRX)?: The estimated 15Y average P/S ratio for OPRX stock is 5.98.

OPRX PS Ratio History

DATE	PS RATIO
2026-10-05	1.66
2026-10-02	1.63
2026-10-01	1.60
2026-09-30	1.59
2026-09-29	1.59
2026-09-28	1.49
2026-09-25	1.53
2026-09-24	1.50
2026-09-23	1.45
2026-09-22	1.45
2026-09-21	1.44
2026-09-18	1.39
2026-09-17	1.45
2026-09-16	1.43
2026-09-15	1.44
2026-09-14	1.49
2026-09-11	1.39
2026-09-10	1.37
2026-09-09	1.37
2026-09-08	1.45
2026-09-04	1.50
2026-09-03	1.51
2026-09-02	1.53
2026-09-01	1.50
2026-08-31	1.52
2026-08-28	1.51
2026-08-27	1.49
2026-08-26	1.48
2026-08-25	1.50
2026-08-24	1.46
2026-08-21	1.47
2026-08-20	1.52
2026-08-19	1.53
2026-08-18	1.57
2026-08-17	1.61
2026-08-14	1.66
2026-08-13	1.53
2026-08-12	1.23
2026-08-11	1.21
2026-08-10	1.20
2026-08-07	1.24
2026-08-06	1.18
2026-08-05	1.21
2026-08-04	1.20
2026-08-03	1.14
2026-07-31	1.06
2026-07-30	1.10
2026-07-29	1.11
2026-07-28	1.11
2026-07-27	1.12
2026-07-24	1.09
2026-07-23	1.09
2026-07-22	1.13
2026-07-21	1.16
2026-07-20	1.14
2026-07-17	1.17
2026-07-16	1.16
2026-07-15	1.16
2026-07-14	1.14
2026-07-13	1.14
2026-07-10	1.12
2026-07-09	1.10
2026-07-08	1.07
2026-07-07	1.10
2026-07-06	1.11
2026-07-02	1.08
2026-07-01	1.06
2026-06-30	1.00
2026-06-29	0.95
2026-06-26	0.89
2026-06-25	0.86
2026-06-24	0.83
2026-06-23	0.79
2026-06-22	0.82
2026-06-18	0.87
2026-06-17	0.89
2026-06-16	0.92
2026-06-15	0.93
2026-06-12	0.91
2026-06-11	0.92
2026-06-10	0.89
2026-06-09	0.89
2026-06-08	0.88
2026-06-05	0.89
2026-06-04	0.94
2026-06-03	0.87
2026-06-02	0.92
2026-06-01	0.94
2026-05-29	0.91
2026-05-28	0.89
2026-05-27	0.85
2026-05-26	0.84
2026-05-22	0.86
2026-05-21	0.86
2026-05-20	0.87
2026-05-19	0.84
2026-05-18	0.89
2026-05-15	0.91
2026-05-14	0.91
2026-05-13	0.87
2026-05-12	1.12
2026-05-11	1.10
2026-05-08	1.14
2026-05-07	1.17
2026-05-06	1.15
2026-05-05	1.17
2026-05-04	1.20
2026-05-01	1.19
2026-04-30	1.10
2026-04-29	1.09
2026-04-28	1.13
2026-04-27	1.14
2026-04-24	1.14
2026-04-23	1.14
2026-04-22	1.20
2026-04-21	1.23
2026-04-20	1.28
2026-04-17	1.27
2026-04-16	1.18
2026-04-15	1.13
2026-04-14	1.07
2026-04-13	1.05
2026-04-10	1.09
2026-04-09	1.09
2026-04-08	1.15
2026-04-07	1.18
2026-04-06	1.20
2026-04-02	1.16
2026-04-01	1.16
2026-03-31	1.11
2026-03-30	1.14
2026-03-27	1.17
2026-03-26	1.23
2026-03-25	1.27
2026-03-24	1.20
2026-03-23	1.14
2026-03-20	1.06
2026-03-19	1.09
2026-03-18	1.12
2026-03-17	1.17
2026-03-16	1.16
2026-03-13	1.13
2026-03-12	1.03
2026-03-11	1.16
2026-03-10	1.14
2026-03-09	1.19
2026-03-06	1.17
2026-03-05	1.31
2026-03-04	1.37
2026-03-03	1.27
2026-03-02	1.28
2026-02-27	1.32
2026-02-26	1.36
2026-02-25	1.35
2026-02-24	1.33
2026-02-23	1.28
2026-02-20	1.42
2026-02-19	1.50
2026-02-18	1.46
2026-02-17	1.44
2026-02-13	1.52
2026-02-12	1.43
2026-02-11	1.60
2026-02-10	1.75
2026-02-09	1.80
2026-02-06	1.89
2026-02-05	1.83
2026-02-04	1.91
2026-02-03	1.78
2026-02-02	1.90
2026-01-30	1.87
2026-01-29	1.88
2026-01-28	1.91
2026-01-27	2.04
2026-01-26	2.02
2026-01-23	2.07
2026-01-22	2.08
2026-01-21	2.03
2026-01-20	2.07
2026-01-16	2.11
2026-01-15	2.19
2026-01-14	2.23
2026-01-13	2.19
2026-01-12	2.44
2026-01-09	2.29
2026-01-08	2.32
2026-01-07	2.41
2026-01-06	2.31
2026-01-05	2.29
2026-01-02	2.16
2025-12-31	2.13
2025-12-30	2.15
2025-12-29	2.13
2025-12-26	2.17
2025-12-24	2.22
2025-12-23	2.21
2025-12-22	2.31
2025-12-19	2.35
2025-12-18	2.36
2025-12-17	2.28
2025-12-16	2.22
2025-12-15	2.29
2025-12-12	2.32
2025-12-11	2.44
2025-12-10	2.41
2025-12-09	2.42
2025-12-08	2.43
2025-12-05	2.47
2025-12-04	2.54
2025-12-03	2.49
2025-12-02	2.45
2025-12-01	2.49
2025-11-28	2.65
2025-11-26	2.67
2025-11-25	2.67
2025-11-24	2.66
2025-11-21	2.53
2025-11-20	2.36
2025-11-19	2.48
2025-11-18	2.45
2025-11-17	2.57
2025-11-14	2.64
2025-11-13	2.69
2025-11-12	2.81
2025-11-11	2.76
2025-11-10	2.87
2025-11-07	2.84
2025-11-06	3.44
2025-11-05	3.48
2025-11-04	3.41
2025-11-03	3.53
2025-10-31	3.72
2025-10-30	3.56
2025-10-29	3.73
2025-10-28	3.82
2025-10-27	3.79
2025-10-24	3.94
2025-10-23	3.56
2025-10-22	3.42
2025-10-21	3.60
2025-10-20	3.69
2025-10-17	3.55
2025-10-16	3.59
2025-10-15	3.70
2025-10-14	3.61
2025-10-13	3.40
2025-10-10	3.28
2025-10-09	3.32
2025-10-08	3.31
2025-10-07	3.26
2025-10-06	3.21
2025-10-03	3.40
2025-10-02	3.20
2025-10-01	3.45
2025-09-30	3.72
2025-09-29	3.72
2025-09-26	3.41
2025-09-25	3.33
2025-09-24	3.34
2025-09-23	3.46

Showing the most recent 260 of 4,395 data points. The chart above shows the full history.

PS Ratio: 1.69

OPRX PS Ratio Chart

OPRX Average PS Ratio Chart

OPRX Current vs Average PS Ratio Chart

OPRX PS Ratio Metrics

OPRX Competitors' PS Ratio

P/S vs. estimated history

Sales Valuation

PS Ratio Formula & Definition

PS Ratio FAQ

OPRX PS Ratio History

Related Metrics